posted on 2025-05-07, 14:03authored byDaria Torodii, Manuel Cordova, Jacob B. Holmes, Pinelopi Moutzouri, Tommaso Casalini, Sten O. Nilsson Lill, Arthur C. Pinon, Christopher S. Knee, Anna Svensk Ankarberg, Okky Dwichandra Putra, Staffan Schantz, Lyndon Emsley
Amorphous
formulations are increasingly used in the pharmaceutical
industry due to their increased solubility, but their structural characterization
at atomic-level resolution remains extremely challenging. Here, we
characterize the complete atomic-level structure of an amorphous glucagon-like
peptide-1 receptor (GLP-1R) agonist using chemical shift driven NMR
crystallography. The structure is determined from measured chemical
shift distributions for 17 of the 32 carbon atoms and 16 of the 31
hydrogen atoms in the molecule. The chemical shifts are able to provide
a detailed picture of the atomic-level conformations and interactions,
and we identify the structural motifs that play a major role in stabilization
of the amorphous form. In particular, hydrogen bonding of the carboxylic
acid proton is strongly promoted, although no carboxylic acid dimer
is formed. Two orientations of the benzodioxole ring are promoted
in the NMR structure, corresponding to a significant stabilization
mechanism. Our observation that inclusion of water leads to stabilization
of the carboxylic acid group might be used as a strategy in future
formulations where hydrogen bonding between neighboring molecules
may otherwise be hindered by sterics.